Shopping Cart
Remove All
Your shopping cart is currently empty
2,5-Di-tert-butylhydroquinone (BHQ) is an effective and selective endoplasmic reticulum Ca2+-ATPase inhibitor.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 g | $29 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $29 | In Stock | In Stock |
| Description | 2,5-Di-tert-butylhydroquinone (BHQ) is an effective and selective endoplasmic reticulum Ca2+-ATPase inhibitor. |
| Targets&IC50 | Ca2+-ATPase:66.7 μM, COX-2:14.1 μM, 5-LOX:1.8 μM |
| In vitro | 2,5-Di-tert-butylhydroquinone shifted the voltage dependence of the steady-state inactivation curve to more negative potentials by 7 mV in the mid-potential of the curve, without affecting the activation curve as well as the time course of I(Ca(L)) inactivation.Preincubation of the cells either with 10 microM cyclopiazonic acid, a SERCA inhibitor, or with 3 mM diethyldithiocarbamate, an inhibitor of intracellular superoxide dismutase (SOD), did not modify 2,5-Di-tert-butylhydroquinone inhibition of I(Ca(L)).On the contrary, this effect was no longer evident when SOD (250 u ml(-1)) was added to the perfusion medium.Either in the presence or in the absence of cells, 2,5-Di-tert-butylhydroquinone gave rise to superoxide anion formation, which was markedly inhibited by the addition of SOD.At micromolar concentrations, 2,5-Di-tert-butylhydroquinone inhibits vascular I(Ca(L)) by giving rise to the formation of superoxide anion which in turn impairs the channel function. |
| Synonyms | BHQ |
| Molecular Weight | 222.32 |
| Formula | C14H22O2 |
| Cas No. | 88-58-4 |
| Smiles | CC(C)(C)C1=CC(O)=C(C=C1O)C(C)(C)C |
| Relative Density. | 1.07 g/cm3 |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (224.9 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (9 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.